| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Siri Helle, Else-Marie Løberg, Rolf Gjestad, Ashley M Schnakenberg Martin, Paul H Lysake. The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition. Psychiatry research. vol 250. 2017-11-16. PMID:28152399. |
there has been a growing link between a history of cannabis use and neurocognitive performance in patients with schizophrenia. |
2017-11-16 |
2023-08-13 |
Not clear |
| Siri Helle, Else-Marie Løberg, Rolf Gjestad, Ashley M Schnakenberg Martin, Paul H Lysake. The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition. Psychiatry research. vol 250. 2017-11-16. PMID:28152399. |
fewer neurocognitive deficits may be a marker of the superior social cognition needed to obtain illicit substances, or cannabis use may indicate a distinct path to schizophrenia with less neurocognitive vulnerability. |
2017-11-16 |
2023-08-13 |
Not clear |
| Ashleigh L Osborne, Nadia Solowij, Katrina Weston-Gree. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. Neuroscience and biobehavioral reviews. vol 72. 2017-10-25. PMID:27884751. |
a systematic review of the effect of cannabidiol on cognitive function: relevance to schizophrenia. |
2017-10-25 |
2023-08-13 |
Not clear |
| Justine Renard, Christopher Norris, Walter Rushlow, Steven R Laviolett. Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments. Neuroscience and biobehavioral reviews. vol 75. 2017-10-24. PMID:28185872. |
neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: implications for novel schizophrenia treatments. |
2017-10-24 |
2023-08-13 |
Not clear |
| Justin Davis, Harris Eyre, Felice N Jacka, Seetal Dodd, Olivia Dean, Sarah McEwen, Monojit Debnath, John McGrath, Michael Maes, Paul Amminger, Patrick D McGorry, Christos Pantelis, Michael Ber. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neuroscience and biobehavioral reviews. vol 65. 2017-10-19. PMID:27073049. |
the development of schizophrenia may be driven by genetic vulnerability interacting with multiple vulnerability factors including lowered prenatal vitamin d exposure, viral infections, smoking intelligence quotient, social cognition cannabis use, social defeat, nutrition and childhood trauma. |
2017-10-19 |
2023-08-13 |
Not clear |
| O Phan, I Obradovic, A Ha. [Consumption of cannabis in adolescents]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. vol 24. issue 1. 2017-10-16. PMID:27889374. |
over the long term, cannabis increases the risk of depression and schizophrenia for those adolescents who are at risk. |
2017-10-16 |
2023-08-13 |
Not clear |
| Karin J H Verweij, Abdel Abdellaoui, Michel G Nivard, Alberto Sainz Cort, Lannie Ligthart, Harmen H M Draisma, Camelia C Minică, Nathan A Gillespie, Gonneke Willemsen, Jouke-Jan Hottenga, Dorret I Boomsma, Jacqueline M Vin. Short communication: Genetic association between schizophrenia and cannabis use. Drug and alcohol dependence. vol 171. 2017-10-04. PMID:28086176. |
short communication: genetic association between schizophrenia and cannabis use. |
2017-10-04 |
2023-08-13 |
Not clear |
| Karin J H Verweij, Abdel Abdellaoui, Michel G Nivard, Alberto Sainz Cort, Lannie Ligthart, Harmen H M Draisma, Camelia C Minică, Nathan A Gillespie, Gonneke Willemsen, Jouke-Jan Hottenga, Dorret I Boomsma, Jacqueline M Vin. Short communication: Genetic association between schizophrenia and cannabis use. Drug and alcohol dependence. vol 171. 2017-10-04. PMID:28086176. |
previous studies have shown a relationship between schizophrenia and cannabis use. |
2017-10-04 |
2023-08-13 |
Not clear |
| Karin J H Verweij, Abdel Abdellaoui, Michel G Nivard, Alberto Sainz Cort, Lannie Ligthart, Harmen H M Draisma, Camelia C Minică, Nathan A Gillespie, Gonneke Willemsen, Jouke-Jan Hottenga, Dorret I Boomsma, Jacqueline M Vin. Short communication: Genetic association between schizophrenia and cannabis use. Drug and alcohol dependence. vol 171. 2017-10-04. PMID:28086176. |
we use two recently developed genomics methods to investigate the genetic overlap between schizophrenia and cannabis use. |
2017-10-04 |
2023-08-13 |
Not clear |
| Michelle S Goodman, Alanna C Bridgman, Rachel A Rabin, Daniel M Blumberger, Tarek K Rajji, Zafiris J Daskalakis, Tony P George, Mera S Bar. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain stimulation. vol 10. issue 2. 2017-09-20. PMID:27964871. |
differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. |
2017-09-20 |
2023-08-13 |
Not clear |
| Michelle S Goodman, Alanna C Bridgman, Rachel A Rabin, Daniel M Blumberger, Tarek K Rajji, Zafiris J Daskalakis, Tony P George, Mera S Bar. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain stimulation. vol 10. issue 2. 2017-09-20. PMID:27964871. |
cannabis is the most commonly used illicit substance among patients with schizophrenia. |
2017-09-20 |
2023-08-13 |
Not clear |
| Michelle S Goodman, Alanna C Bridgman, Rachel A Rabin, Daniel M Blumberger, Tarek K Rajji, Zafiris J Daskalakis, Tony P George, Mera S Bar. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain stimulation. vol 10. issue 2. 2017-09-20. PMID:27964871. |
dysfunctional cortical inhibition has been implicated in the pathophysiology of schizophrenia; however, the effects of cannabis on this mechanism have been relatively unexamined. |
2017-09-20 |
2023-08-13 |
Not clear |
| Michelle S Goodman, Alanna C Bridgman, Rachel A Rabin, Daniel M Blumberger, Tarek K Rajji, Zafiris J Daskalakis, Tony P George, Mera S Bar. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain stimulation. vol 10. issue 2. 2017-09-20. PMID:27964871. |
the goal of this study was to index cortical inhibition from the motor cortex among 4 groups: schizophrenia patients and non-psychiatric controls dependent on cannabis as well as cannabis-free schizophrenia patients and non-psychiatric controls. |
2017-09-20 |
2023-08-13 |
Not clear |
| Pearl L H Mok, Roger T Webb, Louis Appleby, Carsten Bøcker Pederse. Full spectrum of mental disorders linked with childhood residential mobility. Journal of psychiatric research. vol 78. 2017-08-29. PMID:27074536. |
we examined: (1) any substance misuse disorders; specifically alcohol misuse, and cannabis misuse; (2) any personality disorders; specifically antisocial, and borderline personality disorders; (3) schizophrenia and related disorders; specifically schizophrenia, and schizoaffective disorder; (4) any mood disorders; specifically bipolar disorder, and depressive disorder; (5) any anxiety and somatoform disorders; specifically obsessive compulsive disorder; (6) any eating disorders; specifically anorexia nervosa. |
2017-08-29 |
2023-08-13 |
Not clear |
| Rebecca C Hanna, Alexandra Shalvoy, C Munro Cullum, Elena I Ivleva, Matcheri Keshavan, Godfrey Pearlson, S Kristian Hill, John A Sweeney, Carol A Tamminga, Subroto Ghos. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia bulletin. vol 42. issue 6. 2017-07-24. PMID:27033329. |
prior cannabis use, compared to nonuse, is reported to be associated with less cognitive impairment in schizophrenia. |
2017-07-24 |
2023-08-13 |
human |
| Rebecca C Hanna, Alexandra Shalvoy, C Munro Cullum, Elena I Ivleva, Matcheri Keshavan, Godfrey Pearlson, S Kristian Hill, John A Sweeney, Carol A Tamminga, Subroto Ghos. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia bulletin. vol 42. issue 6. 2017-07-24. PMID:27033329. |
the a priori hypothesis tested was that individuals with psychosis and a history of adolescent cannabis use (acu) would have better global neuropsychological performance, as measured by the brief assessment of cognition in schizophrenia (bacs) battery, compared to those with psychosis and no cannabis use history. |
2017-07-24 |
2023-08-13 |
human |
| Arianna Marconi, Marta Di Forti, Cathryn M Lewis, Robin M Murray, Evangelos Vasso. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia bulletin. vol 42. issue 5. 2017-07-19. PMID:26884547. |
a logistic regression model gave an or of 3.90 (95% ci 2.84 to 5.34) for the risk of schizophrenia and other psychosis-related outcomes among the heaviest cannabis users compared to the nonusers. |
2017-07-19 |
2023-08-13 |
Not clear |
| Taiwo Babatope, Jigar Chotalia, Rania Elkhatib, Satyajit Mohite, Joel Shah, Sumana Goddu, Ruchir Arvind Patel, Osarhiemen Ruth Aimienwanu, Devanshu Patel, Titilayo Makanjuola, Olaoluwa O Okusag. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. The Psychiatric quarterly. vol 87. issue 4. 2017-07-14. PMID:26875104. |
a study of the impact of cannabis on doses of discharge antipsychotic medication in individuals with schizophrenia or schizoaffective disorder. |
2017-07-14 |
2023-08-13 |
Not clear |
| Taiwo Babatope, Jigar Chotalia, Rania Elkhatib, Satyajit Mohite, Joel Shah, Sumana Goddu, Ruchir Arvind Patel, Osarhiemen Ruth Aimienwanu, Devanshu Patel, Titilayo Makanjuola, Olaoluwa O Okusag. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. The Psychiatric quarterly. vol 87. issue 4. 2017-07-14. PMID:26875104. |
patients with schizophrenia or schizoaffective disorder have a high prevalence of comorbid cannabis use disorder (cud). |
2017-07-14 |
2023-08-13 |
Not clear |
| Taiwo Babatope, Jigar Chotalia, Rania Elkhatib, Satyajit Mohite, Joel Shah, Sumana Goddu, Ruchir Arvind Patel, Osarhiemen Ruth Aimienwanu, Devanshu Patel, Titilayo Makanjuola, Olaoluwa O Okusag. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. The Psychiatric quarterly. vol 87. issue 4. 2017-07-14. PMID:26875104. |
we compared doses of antipsychotic medications at the time of discharge from hospital among inpatients with schizophrenia or schizoaffective disorder with or without concurrent cannabis use. |
2017-07-14 |
2023-08-13 |
Not clear |